Fundraising Fox

Helen Kim

Investor

Partner at The Column Group

Santa Monica, California

Writes $100K – $10M checks · typically $1M

About

Helen Kim serves on the board of directors at Prothena Corporation plc and as a board member at Applied Molecular Transport. She has held executive management positions at NGM Biopharmaceuticals, Kosan, Affymax, Onyx, Protein Design Labs, and Chiron. Kim holds a BS in Chemical Engineering from Northwestern University and an MBA from the University of Chicago.

Experience

  1. Prothena Corporation plcMember Board of Directorscurrent2022 — present
  2. InduProMember Board of Directorscurrent2022 — present
  3. Protego BiopharmaMember Board of Directorscurrent2021 — present
  4. Aktis OncologyMember Board of Directorscurrent2021 — present
  5. IconOVir BioMember Board of Directorscurrent2020 — present
  6. ReCode TherapeuticsMember Board of Directorscurrent2020 — present
  7. Vida Ventures, LLCSenior Managing Directorcurrent2019 — presentSanta Monica, CA
  8. A2 Biotherapeutics, Inc.Board Membercurrent2019 — present
  9. Applied Molecular TransportBoard Member2018 — 2022South San Francisco
  10. Assembly Biosciences, Inc.Member Board Of Directors2018 — 2020
  11. ExicureBoard Member2014 — 2020Greater Chicago Area
  12. The Column GroupPartner2018 — 2019San Francisco Bay Area
  13. Kite Pharma, Inc.Executive Vice President2014 — 2018Santa Monica, CA
  14. Forsight Vision 4Board Member2012 — 2017
  15. Sunesis PharmaceuticalsBoard Director2009 — 2016
  16. NGM Biopharmaceuticals, Inc.Strategic Advisor formerly Chief Business Officer2009 — 2014
  17. ImmunoCellular Therapeutics LtdBoard member2011 — 2014Calabasas
  18. West Coast Clinical Trials, GlobalBoard director2011 — 2012Costa Mesa, CA
  19. Trinity BiosystemsBoard member2009 — 2010
  20. Kosan BiosciencesPresident and CEO2007 — 2008

Education

  1. The University of Chicago Booth School of BusinessMBA1986 — 1988
  2. Northwestern UniversityBS, Chemical Engineering1981 — 1985

Colleagues at The Column Group

Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
Hui Tian
Partner at The Column Group
Hui Tian, PhD
Partner at The Column Group
James Evangelista
Partner and CFO at The Column Group
JeenJoo Kang
Venture Partner at The Column Group

Network1

Carla Daniel
Partner at The Column Group

Investors connected to Helen in public investor directories — a warm-intro map.

Frequently asked questions

Where does Helen Kim work?
Helen Kim is Partner at The Column Group.
What check size does Helen Kim write?
Helen Kim typically writes checks of $100K – $10M.

Same school

Also attended The University of Chicago Booth School of Business476

Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital

+ 470 more

Also attended Northwestern University337

Hannah KrootMarketing Lead at Intel CapitalMikowai AshwillInvestor at Spark CapitalNaomi Pilosof IonitaBoard Partner at Menlo VenturesEric OngInvestor at LightbankBill PescatelloInvestor at LightbankScott JacobsonManaging Director at Madrona Venture Group

+ 331 more

Shared employers

Also worked at Assembly Biosciences, Inc.1

Uri LopatinInvestor at Khosla Ventures

Also worked at NGM Biopharmaceuticals, Inc.3

Hui TianPartner at The Column GroupSiobhan Nolan ManginiPartner at VenrockLinda TsangExecutive Assistant at Venrock

Also worked at Chiron11

Annalisa D'AndreaVenture Partner at Longwood FundAlexia PerouseManaging Partner and CEO at iBionextDion MadsenPartner at Amplitude Venture CapitalBeckie RobertsonVenture Advisor at Intuitive VenturesLisa Wisniewski, PhDManaging Director at Global BioAccess FundKristin Torres MowatPartner at Health Velocity Capital

+ 5 more